PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
07.05.25
/
50%
€36.20
Target price
07.05.26
€51.13
Performance (%)
60.22%
Price
20.03.26
€58.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc. has seen massive gains of 60.22%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 3.571% | 3.571% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Royal Bank of Canada from $57.00 to $58.00. They now have an "outperform" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€61.50
05.11.25
05.11.25
€71.35
05.11.26
05.11.26
-5.69%
20.03.26
20.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
22.04.25
22.04.25
€56.55
22.04.26
22.04.26
39.42%
20.03.26
20.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.40
18.02.25
18.02.25
€60.28
18.02.26
18.02.26
22.36%
19.02.26
19.02.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€59.86
03.12.25
03.12.25
28.02%
04.12.25
04.12.25